Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases

被引：4

作者：

Trobisch, Andreas ^{[1
,2
]}

Marterer, R. ^{[3
]}

Gorkiewicz, G. ^{[4
]}

Flaschberger, S. ^{[5
]}

Lackner, H. ^{[1
]}

Seidel, M. ^{[1
]}

Sperl, D. ^{[1
]}

Karastaneva, A. ^{[1
]}

Kohlmaier, B. ^{[1
]}

Egger, M. ^{[6
]}

Urban, C. ^{[1
]}

Benesch, M. ^{[1
]}

Strenger, V ^{[1
,6
,7
]}

机构：

[1] Med Univ, Dept Paediat & Adolescent Med, Div Paediat Haematol Oncol, Graz, Austria

[2] Med Univ, Dept Paediat & Adolescent Med, Div Neonatol, Graz, Austria

[3] Med Univ Graz, Dept Radiol, Div Paediat Radiol, Graz, Austria

[4] Med Univ, Diagnost & Res Inst Pathol, Graz, Austria

[5] Klinikum Klagenfurt Worthersee, Dept Paediat, Klagenfurt, Austria

[6] Med Univ, Dept Paediat & Adolescent Med, Div Paediat Pulmonol & Allergol, Graz, Austria

[7] Med Univ, Res Unit Infect Dis Immunocompromised Host, Graz, Austria

来源：

SUPPORTIVE CARE IN CANCER | 2020年 / 28卷 / 05期

关键词：

ALL; Mucormycosis; IFD; Antimycotic treatment; Chemotherapy; LIPOSOMAL AMPHOTERICIN-B; ACTINOMUCOR-ELEGANS; EUROPEAN ORGANIZATION; FUNGAL-INFECTIONS; DIAGNOSIS; GUIDELINES;

D O I：

10.1007/s00520-019-04962-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and intermittent additional posaconazole was continued until immune reconstitution 7 months after the end of ALL treatment. Repeated imaging guided treatment decisions. Twenty-six and 19 months after the end of ALL treatment and antifungal treatment, respectively, the patient is still in the first complete remission and shows no signs of active invasive fungal disease (IFD).

引用

页码：2157 / 2161

页数：5

共 10 条

[1] Invasive mucormycosis during treatment for acute lymphoblastic leukaemia—successful management of two life-threatening diseases
Andreas Trobisch
R. Marterer
G. Gorkiewicz
S. Flaschberger
H. Lackner
M. Seidel
D. Sperl
A. Karastaneva
B. Kohlmaier
M. Egger
C. Urban
M. Benesch
V. Strenger
Supportive Care in Cancer, 2020, 28 : 2157 - 2161
[2] SUCCESSFUL TREATMENT OF INVASIVE THORACOPULMONARY MUCORMYCOSIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
FUKUSHIMA, T
SUMAZAKI, R
SHIBASAKI, M
SAITOH, H
FUJIGAKI, Y
KANEKO, M
AKAOGI, E
MITSUI, K
OGATA, T
TAKITA, H
CANCER, 1995, 76 (05) : 895 - 899
[3] Successful management of hepatic mucormycosis in an acute lymphoblastic leukaemia patient: a case report and review of the literature
Tuysuz, Gulen
Ozdemir, Nihal
Senyuz, Osman Faruk
Emre, Senol
Kantarcioglu, Serda
Adaletli, Ibrahim
Kepil, Nuray
Tutuncu, Cigdem
Celkan, Tiraje
MYCOSES, 2014, 57 (08) : 513 - 518
[4] Life-threatening complications associated with acute monocytic leukaemia after dental treatment
Koulocheris, P.
Metzger, M. R.
Kesting, M. R.
Hohlweg-Majert, B.
AUSTRALIAN DENTAL JOURNAL, 2009, 54 (01) : 45 - 48
[5] Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature
Pomorska, Anna
Malecka, Anna
Jaworski, Radoslaw
Radon-Proskura, Julia
Hare, Rasmus Kroger
Nielsen, Henrik Vedel
Andersen, Lee O'Brian
Jensen, Henrik Elvang
Arendrup, Maiken Cavling
Irga-Jaworska, Ninela
MYCOPATHOLOGIA, 2019, 184 (01) : 81 - 88
[6] Practical Recommendations in the Treatment of Acute and Chronic Life-Threatening Infectious Diseases in Patients with Acute Hepatic Porphyria
Badia, Bruno de Mattos Lombardi
Serrano, Paulo de Lima
Barile, Joao Paulo
Seneor, Daniel Delgado
Mendes, Patricia Marques
Cavalheiro, Renan Brandao Rambaldi
Peixoto, Kaliny Oliveira
Farias, Igor Braga
Machado, Roberta Ismael Lacerda
Pinto, Wladimir Bocca Vieira de Rezende
Oliveira, Acary Souza Bulle
Sgobbi, Paulo
METABOLITES, 2025, 15 (02)
[7] Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia
Erker, Craig
Huppler, Anna R.
Walsh, Thomas J.
McCormick, Michael E.
Suchi, Mariko
Bhatt, Neel S.
Kehl, Susan C.
Southwood, Jessica
Harker-Murray, Paul
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (07) : E446 - E449
[8] Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature
Anna Pomorska
Anna Malecka
Radoslaw Jaworski
Julia Radon-Proskura
Rasmus Krøger Hare
Henrik Vedel Nielsen
Lee O’Brian Andersen
Henrik Elvang Jensen
Maiken Cavling Arendrup
Ninela Irga-Jaworska
Mycopathologia, 2019, 184 : 81 - 88
[9] Successful medical management of an acute life-threatening haemorrhagic crisis related to acquired colonic vascular ectasia in a dog
Paulin, Mathieu Victor
Cosford, Kevin
Sato-Takada, Kanae
Koo, Siu To
Carr, Anthony
VETERINARY RECORD CASE REPORTS, 2022, 10 (04):
[10] Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands
Schwartz, Emily R.
Rensen, Niki
Steur, Lindsay M. H.
Gemke, Reinoud
van Eijkelenburg, Natasha K. A.
van der Sluis, Inge M.
Dors, Natasja
van den Bos, Cor
Tissing, Wim J. E.
Grootenhuis, Martha A.
Kaspers, Gertjan J. L.
Van Litsenburg, Raphaele R. L.
BMJ OPEN, 2023, 13 (10):

← 1 →